Wegovy Pill Will Be Available Early Next Year

The FDA has approved a pill form of the popular GLP-1 weight-loss medication Wegovy. Novo Nordisk says it is as effective as an injectable.

Wegovy pill approval sends Novo Nordisk stock soaring. What it means for Eli Lilly.

Novo shares were rallying after it announced late Monday that the U.S. Food and Drug Administration (FDA) approved a pill version of Wegovy—the weight-loss version of the Danish company’s groundbreaking Ozempic drug and a competitor to Eli Lilly’s Zepbound.

Forbes Daily: Novo Nordisk’s Wegovy Pill Set To Hit The Market In January

Today’s Forbes Daily newsletter features the FDA approval of Wegovy pill, gold prices rise again, AI data centers in space, Larry Ellison backs Paramount bid and more.

Novo's Wegovy pill to test demand from consumers with cash

Novo Nordisk's newly approved weight-loss pill version of Wegovy will be a test case for the fast-growing cash-paying consumer market, with plans for the first highly effective oral treatment to go straight to U.

A cheaper, easier-to-use version of Wegovy is coming to the US soon

Wegovy's new pill has been approved in the US, offering a needle-free option with a lower starting price than injections.

Wegovy Pill Launch Promises Change — But Its Cost and What It Does Could Decide Who Gets Help

The Wegovy pill has been approved, but questions over cost and access could shape who benefits from the new oral weight-loss treatment.
Feedback